Shield Therapeutics plc (SHIEF)

Shield Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	153	26	67	22	130	102
Market Cap Growth	480.39%	-60.39%	202.91%	-83.06%	27.56%	-63.30%
Enterprise Value	169	38	59	19	99	93
Last Close Price	0.15	0.03	0.08	0.08	0.56	1.33
PS Ratio	3.68	0.82	5.10	4.01	63.24	7.19
PB Ratio	-10.28	-20.07	4.44	3.37	2.36	2.47
P/TBV Ratio	-	-	4.82	4.15	4.11	6.53
P/FCF Ratio	30.24	-	-	-	-	-
P/OCF Ratio	30.23	-	-	-	-	-
EV/Sales Ratio	4.09	1.19	4.50	3.48	48.36	6.56
EV/EBITDA Ratio	-	-	-	-	-	2840.59
EV/FCF Ratio	33.43	-	-	-	-	-
Debt / Equity Ratio	-1.82	-20.02	1.35	1.04	0.00	0.00
Debt / EBITDA Ratio	-	-	-	-	-	1.17
Debt / FCF Ratio	5.35	-	-	-	-	-
Net Debt / Equity Ratio	-1.09	-15.07	0.42	0.52	-0.29	-0.10
Net Debt / EBITDA Ratio	-1.13	-0.89	-0.20	-0.11	0.64	-121.33
Net Debt / FCF Ratio	3.21	-2.92	-0.17	-0.15	0.64	2.08
Asset Turnover	0.76	0.61	0.35	0.14	0.04	0.30
Inventory Turnover	3.98	3.89	3.65	1.63	0.65	1.16
Quick Ratio	0.69	0.90	1.83	0.62	3.73	1.60
Current Ratio	0.83	1.16	2.28	0.95	4.64	2.32
Return on Equity (ROE)	-	-396.36%	-308.60%	-179.19%	-55.46%	-8.43%
Return on Assets (ROA)	-16.77%	-26.90%	-51.93%	-49.37%	-32.97%	-3.91%
Return on Capital Employed (ROCE)	-120.80%	-92.00%	-89.40%	-229.50%	-49.90%	-7.10%
Earnings Yield	-13.90%	-102.83%	-49.88%	-225.97%	-20.48%	-3.52%
FCF Yield	3.31%	-25.74%	-55.98%	-102.82%	-19.40%	-1.87%
Buyback Yield / Dilution	-19.74%	-8.33%	-209.85%	-14.08%	-74.36%	-0.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.